首页> 美国卫生研究院文献>other >Severing corneal nerves in one eye induces sympathetic loss of immune privilege and promotes rejection of future corneal allografts placed in either eye
【2h】

Severing corneal nerves in one eye induces sympathetic loss of immune privilege and promotes rejection of future corneal allografts placed in either eye

机译:一只眼睛的角膜神经切断会导致交感神经系统免疫特权的丧失并促进排斥放置在两只眼睛中的未来角膜同种异体移植物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Less than 10% of corneal allografts undergo rejection even though HLA matching is not performed. However, second corneal transplants experience a three-fold increase in rejection, which is not due to prior sensitization to histocompatibility antigens shared by the first and second transplants since corneal grafts are selected at random without histocompatibility matching. Using a mouse model of penetrating keratoplasty we found that 50% of the initial corneal transplants survived, yet 100% of the subsequent corneal allografts (unrelated to the first graft) placed in the opposite eye underwent rejection. The severing of corneal nerves that occurs during surgery induced substance P (SP) secretion in both eyes, which disabled T regulatory cells that are required for allograft survival. Administration of an SP antagonist restored immune privilege and promoted graft survival. Thus, corneal surgery produces a sympathetic response that permanently abolishes immune privilege of subsequent corneal allografts, even those placed in the opposite eye and expressing a completely different array of foreign histocompatibility antigens from the first corneal graft.
机译:即使不进行HLA匹配,也只有不到10%的角膜同种异体移植发生排斥反应。然而,第二次角膜移植物的排斥反应增加了三倍,这不是由于对第一和第二次移植物共有的组织相容性抗原的事先敏化,因为随机选择了角膜移植物而没有组织相容性匹配。使用穿透性角膜移植的小鼠模型,我们发现有50%的初始角膜移植幸存下来,但是放置在另一只眼睛中的100%的后续角膜同种异体移植物(与第一个移植物无关)经历了排斥反应。手术期间发生的角膜神经切断导致两只眼睛的物质P(SP)分泌,这使异体移植存活所需的T调节细胞失活。 SP拮抗剂的施用恢复了免疫特权并促进了移植物存活。因此,角膜手术产生的交感反应永久性地消除了随后的角膜同种异体移植物的免疫特权,即使是那些放在另一只眼中并表达出与第一个角膜移植物完全不同的外源组织相容性抗原的移植物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号